What are the CT (Computed Tomography) specific findings for hypersensitivity pneumonitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CT Findings in Hypersensitivity Pneumonitis

The key CT findings in hypersensitivity pneumonitis (HP) are ground-glass opacities, mosaic attenuation, air trapping on expiratory images, and ill-defined centrilobular nodules, with different patterns distinguishing nonfibrotic from fibrotic HP. 1, 2

Nonfibrotic HP CT Findings

  • Diffusely distributed ground-glass opacities (GGO) and mosaic attenuation are characteristic features of lung infiltration in nonfibrotic HP 1, 2
  • Ill-defined, small (<5 mm) centrilobular nodules on inspiratory images are highly suggestive of nonfibrotic HP 1
  • Air trapping on expiratory CT images is a key diagnostic feature and should be specifically evaluated with expiratory imaging 1, 3
  • Craniocaudal distribution is typically diffuse without zonal predominance 2
  • Axial distribution is typically diffuse without central or peripheral predominance 2, 4
  • The "three-density pattern" may be present, showing normal lung attenuation, ground-glass opacities, and decreased attenuation (air trapping) 1, 2

Fibrotic HP CT Findings

  • Coexisting lung fibrosis and signs of bronchiolar obstruction (mosaic attenuation, air trapping) are highly suggestive of fibrotic HP 1, 2
  • Irregular fine or coarse reticulation with architectural distortion is a typical manifestation of fibrosis in HP 1, 5
  • Septal thickening with or without traction bronchiectasis in areas of ground-glass opacities is commonly seen 1, 2
  • Fibrosis is typically most severe in the mid or mid and lower lung zones 1, 6
  • Relative basal sparing helps differentiate fibrotic HP from idiopathic pulmonary fibrosis 1, 2
  • On axial images, there is often no central or peripheral predominance of lung fibrosis, though peripheral distribution may be seen in some cases 1, 6
  • Honeycombing may be present in severe forms of fibrotic HP 1, 5

Prognostic CT Findings

  • The presence of air trapping and mosaic attenuation on CT is associated with better survival in chronic HP 7
  • Traction bronchiectasis and increased pulmonary artery/aorta ratio are associated with worse survival 6
  • CT pattern of usual interstitial pneumonia (UIP) or probable UIP is an independent risk factor for fibrotic progression and acute exacerbation 5
  • Ground-glass opacity predominance (without extensive fibrosis) is associated with improved survival 6

Recommended CT Acquisition Parameters

  • Noncontrast examination is standard 1, 2
  • Volumetric acquisition with submillimetric collimation is recommended 1
  • Thin-section CT images (<1.5 mm) using a high-spatial-frequency algorithm 1
  • Both inspiratory and expiratory acquisitions are essential to evaluate for air trapping 1, 2
  • Recommended radiation dose is 1-3 mSv ("reduced" dose) 1
  • Prone imaging is optional but may help differentiate dependent atelectasis from true pathology 1

Diagnostic Pitfalls and Caveats

  • CT findings alone are insufficient for definitive diagnosis of HP, especially in fibrotic HP where appearances can overlap with other interstitial lung diseases 2, 6
  • Smoking may decrease the typical HP appearance on CT and increase the likelihood of a UIP-like pattern 6
  • The CT appearance of chronic HP can mimic nonspecific interstitial pneumonia (NSIP) or usual interstitial pneumonia (UIP) patterns 3, 6
  • Fibrotic progression in chronic HP often shows persistent areas of mosaic attenuation that are eventually replaced by fibrosis 5
  • Integration with exposure history, clinical information, and multidisciplinary discussion is essential for accurate diagnosis 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.